A new strategy to stop metastasis ($2M)
A new strategy to stop metastasis ($2M)
We know that once cancer metastasizes, survival rates plummet. But how and why metastasis occurs is itself poorly understood. Dr. Cools-Lartigue is testing a ground-breaking therapeutic strategy to stop cancer metastasizing, focusing on the role of neutrophils and systemic inflammation.
“Instead of killing cancer cells, what makes our immune system adopt a tolerant stance that permits ongoing tumor growth and spread? If we change our concept of cancer to a disease of the immune system, the failure of our treatment strategies to date becomes less perplexing. No current treatment effort specifically addresses this abnormal immune function.”
Dr. Jonathan Cools-Lartigue
Thoracic Surgeon, Clinician Scientist, MUHC
Dr. Jonathan Cools-Lartigue
Dr. Cools-Lartigue’s research group was the first to describe Neutrophil Extractor Traps (NETs) as facilitators of cancer development in the context of inflammation.
More news
Better Access to Clinical Trials Could Save the Lives of Cancer Patients
After coughing up blood one day, Armen, a security guard at the Montreal General Hospital (MGH-MUHC), was diagnosed with stage 3 lung cancer.
The Making of Together Against Cancer
Here are some of the people who give their best in the fight against cancer.
Together Against Cancer: Campaign Announcement
The Cedars Cancer Foundation and the Montreal General Hospital Foundation are joining forces to fight cancer and launch a major fundraising campaign, with a goal of $100 million.